Related Experiment Video
Updated: May 25, 2026

Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy
Published on: June 25, 2013
Intravenous lidocaine has no impact on rocuronium-induced neuromuscular block. Randomised study
C Czarnetzki1, C Lysakowski, N Elia
1Division of Anaesthesiology, Geneva University Hospitals, Geneva, Switzerland. christoph.czarnetzki@hcuge.ch
Intravenous lidocaine infusion does not alter the duration of rocuronium-induced neuromuscular blockade in surgical patients. This study found no significant differences in onset, recovery, or clinical duration of the block with lidocaine compared to saline.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Intravenous lidocaine use is rising in surgical settings.
- Lidocaine possesses neuromuscular blocking properties, necessitating investigation into its interaction with muscle relaxants.
Purpose of the Study:
- To evaluate the effect of continuous intravenous lidocaine infusion on the time course of neuromuscular blockade induced by rocuronium.
Main Methods:
- A randomized controlled trial involving 52 adult surgical patients.
- Participants received either intravenous lidocaine or saline infusion throughout surgery.
- Neuromuscular transmission was monitored using acceleromyography (train-of-four).
Main Results:
- No significant differences were observed in the onset time of neuromuscular blockade.
- Total recovery time, clinical duration, and recovery index showed no statistically significant variations between the lidocaine and saline groups.
- Specific metrics like onset time (113.9s vs 119.5s) and total recovery time (58.1min vs 54.3min) were comparable.
Conclusions:
- Continuous intravenous lidocaine infusion does not impact the time course of neuromuscular blockade induced by a standard intubation dose of rocuronium.
- The findings suggest that lidocaine does not potentiate or antagonize the effects of rocuronium on neuromuscular transmission.
Related Concept Videos
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Depolarizing Blockers: Pharmocokinetics
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
